Primary nasal and nasopharyngeal lymphomas: A comparative study of clinical presentation and treatment outcome

Clinical Oncology

Volumn 11, Issue 6, 1999, Pages 379-387

  Lei, K I K ^a   Suen, J J S ^a   Hui, P ^a   Tong, M ^a   Li, W ^a   Yau, S H ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Biological behaviour; Nasal lymphoma; Nasopharyngeal lymphoma

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; PREDNISOLONE; PREDNISONE; VINCRISTINE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; EPISTAXIS; FEMALE; HEARING IMPAIRMENT; HUMAN; IMMUNOPHENOTYPING; MALE; NASOPHARYNX CANCER; NOSE CANCER; NOSE OBSTRUCTION; PRIORITY JOURNAL; PROGNOSIS; T CELL LYMPHOMA; TREATMENT OUTCOME;

EID: 0033378022     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1053/clon.1999.9088     Document Type: Article

References (46)

1. Ratech H, Burke J S, Blayney D W. A clinicopathologic study of malignant lymphomas of the nose, paranasal sinuses, and hard palate, including cases of lethal midline granuloma. Cancer. 64:1989;2525-2531.
2. Otter R, Gerritis W BJ, Sandt M MVD. Primary extranodal and nodal non-Hodgkin's lymphoma: a survey of a population-based registry. Eur J Cancer Clin Oncol. 25:1989;1203-1210.
3. Ferry J A, Sklar J, Zukerberg L R. Nasal lymphoma. A clinicopathologic study with immunophenotypic and genotypic analysis. Am J Surg Pathol. 15:1991;268-279.
4. Ho F CS, Todd D, Loke S L. Clinico-pathological features of malignant lymphomas in 294 Hong Kong Chinese patients: retrospective study covering an eight-year period. Int J Cancer. 34:1984;143-148.
5. Ng C S, Chan J KC, Lo S TH. Immunophenotypic analysis of non-Hodgkin's lymphomas in Chinese: a study of 75 cases in Hong Kong. Pathology. 18:1986;419-425.
6. Arber D A, Weiss L M, Albujar P F. Nasal lymphoma in Peru: high incidence of T-cell immunophenotype and Epstein-Barr virus infection. Am J Surg Pathol. 17:1993;392-399.
7. Chan J KC, Ng C S, Lau W H. Most nasal/nasopharyngeal lymphomas are peripheral T-cell lymphomas. Am J Surg Pathol. 11:1987;418-429.
8. Ye Y L, Zhou M H, Lu X Y. Nasopharyngeal and nasal malignant lymphoma: a clinicopathologic study of 54 cases. Histopathology. 20:1992;511-516.
9. Weiss L M, Arber D A, Strickler J G. Nasal T-cell lymphoma. Ann Oncol. 5(suppl 10):1994;S39-S42.
10. Abbondanzo S L, Wenig B M. Non-Hodgkin's lymphoma of the sinonasal tract. A clinicopathologic and immunophenotypic study of 120 cases. Cancer. 75:1995;1281-1291.
11. Petrella T, Delfau-Larue M H, Caillot D. Nasopharyngeal lymphomas: further evidence for natural killer cell origin. Hum Pathol. 27:1996;827-833.
12. Ramsay A D, Rooney N. Lymphomas of the head and neck. 1: nasofacial T-cell lymphoma. Eur J Cancer B Oral Oncol. 29B:1993;99-102.
13. Eichel B S, Harrison E G, Devine K D. Primary lymphoma of the nose including a relationship to lethal midline granuloma. Am J Surg. 112:1966;597-605.
14. Pathologic and clinical spectrum of post-thymic T-cell malignancies. Cancer Invest. 2:1984;413-426.
15. Lipford E H, Margolick J B, Longo D L. Angiocentric immunoproliferative lesions: a clinicopathologic spectrum of post-thymic T-cell proliferation. Blood. 72:1988;1674-1681.
16. Harris N L, Jaffe E S, Stein H. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 84:1994;1361-1392.
17. Liang R, Todd D, Chan T K. Nasal lymphoma. A retrospective analysis of 60 cases. Cancer. 66:1990;2205-2209.
18. Shima N, Kobashi Y, Tsutsui K. Extranodal non- Hodgkin's lymphoma of the head and neck. Cancer. 66:1990;1190-1197.
19. Ng C S, Chan J KC, Lo S TH. Expression of natural killer cell markers in non-Hodgkin's lymphoma. Hum Pathol. 18:1987;1257-1262.
20. Ho F CS, Choy D, Loke S L. Polymorphic reticulosis and conventional lymphomas of the nose and upper aerodigestive tract: a clinicopathologic study of 70 cases, and immunophenotypic studies of 16 cases. Hum Pathol. 21:1990;1041-1050.
21. Kanavaros P, Lescs M C, Briére J. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood. 81:1993;2688-2695.
22. Jaffe E S. Nasal and nasal-type T/NK cell lymphoma: a unique form of lymphoma associated with the Epstein-Barr virus [commentary]. Histopathology. 27:1995;581-583.
23. Jaffe E S, Chan J KC, Su I J. Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas. Definitions, differential diagnosis, and epidemiology. Am J Surg Pathol. 20:1996;103-111.
24. Jaffe E S. Classification of natural killer (NK) cell and NKlike T-cell malignancies [editorial]. Blood. 87:1996;1207-1210.
25. Strickler J G, Meneses M F, Habermann T M. Polymorphic reticulosis: a reappraisal. Hum Pathol. 25:1994;659-665.
26. Davison S P, Habermann T M, Strickler J G. Nasal and nasopharyngeal angiocentric T-cell lymphomas. Laryngoscope. 106:1996;139-143.
27. Nakamura S, Katoh E, Koshikawa T. Clinicopathologic study of nasal T/NK-cell lymphoma among the Japanese. Pathol Int. 47:1997;38-53.
28. Robbins K T, Kong J S, Fuller L M. A comparative analysis of lymphomas involving Waldeyer's ring and the nasal cavity and the paranasal sinuses. Otolaryngology. 14:1985;7-13.
29. Jacobs C, Weiss L, Hoppe R T. The management of extranodal head and neck lymphomas. Arch Otolaryngol Head Neck Surg. 112:1986;654-658.
30. Ossenkoppele G J, Mol J J, Snow G B. Radiotherapy versus radiotherapy plus chemotherapy in Stage I and II non- Hodgkin's lymphoma of the upper digestive and respiratory tract. Cancer. 60:1987;1505-1509.
31. Economopoulos T, Asprous N, Stathakis N. Primary extranodal non-Hodgkin's lymphoma of the head and neck. Oncology. 49:1992;484-488.
32. Aviles A, Rodriguez L, Guzman R G. Angiocentric T- cell lymphoma of the nose, paranasal sinuses and hard palate. Hematol Oncol. 10:1992;141-147.
33. Cheung M MC, Chan J KC, Lau W H. Primary non- Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients. J Clin Oncol. 16:1998;70-77.
34. Carbone P P, Kaplan H S, Musshoff K. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res. 31:1971;1860-1861.
35. Kaplan E L, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
36. Stansfeld A, Diebold J, Kapanci Y. Updated Kiel classification for lymphomas. Lancet. i:1988;292-293.
37. Cancer. 49:1982;2112-2135.
38. Ho J HC. Nasopharynx. Halnan K E. Treatment of cancer. 1982;249-268 Igaku-Shoin, New York:
39. Chan K JC, Ng C S, Lo S TH. Immunohistological characterization of malignant lymphomas of the Waldeyer's ring other than the nasopharynx. Histopathology. 11:1987;885-899.
40. Liang R, Todd D, Chan T K. Treatment outcome and prognostic factors for primary nasal lymphoma. J Clin Oncol. 13:1995;666-670.
41. Tran L M, Mark R, Fu Y S. Primary non-Hodgkin's lymphomas of the paranasal sinuses and nasal cavity. A report of 18 cases with stage IE disease. Am J Clin Oncol. 15:1992;222-225.
42. Logsdon M D, Ha C S, Kavadi V S. Lymphoma of the nasal cavity and paranasal sinuses. Improved outcome and altered prognostic factors with combined modality therapy. Cancer. 80:1997;477-488.
43. .Li, Y, X, Coucke, P, A, Li, J, Y, et al. Primary non-Hodgkin's lymphoma of the nasal cavity. Prognostic significance of paranasal extension and the role of radiotherapy. 1998;83:449-56.
44. Shikama N, Izuno I, Oguchi M. Clinical Stage IE primary lymphoma of the nasal cavity: radiation therapy and chemotherapy. Radiology. 204:1997;467-470.
45. Rockwell S. Oxygen delivery: implications for the biology and therapy of solid tumors. Oncol Res. 9:1997;383-390.
46. Yamaguchi M, Kia K, Miwa H. Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells. Cancer. 76:1995;2351-2356.